–
Skye Bioscience, Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
millions USD
FY21:
FY22:
0
FY23:
0
FY24:
0
FY25:
–
(positive)
Change from FY21 to FY25
millions USD
FY21:
−7.85
FY22:
−18.3
FY23:
−34.7
FY24:
−30.2
FY25:
−58.2
(positive)
Change from FY21 to FY25
millions USD
FY21:
−7.81
FY22:
–
FY23:
–
FY24:
–
FY25:
−55.6
(positive)
Change from FY21 to FY25
millions USD
FY21:
−8.52
FY22:
−19.5
FY23:
−37.6
FY24:
−26.6
FY25:
−55.9
(positive)
Change from FY21 to FY25
millions USD
FY21:
−8.52
FY22:
−19.5
FY23:
−37.6
FY24:
−26.6
FY25:
−55.9
All amounts in millions USD